|
|
Article: Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer.
- Article from:
- Business Wire
- Article date:
- October 25, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONROVIA, Calif. -- Xencor, a company developing protein and antibody therapeutics, today announced the appointment of Jeffrey D. Bloss, M.D., F.A.C.O.G., as chief medical officer. Dr. Bloss will leverage more than 15 years of clinical practice, research and drug development experience to direct Xencor's clinical and preclinical development strategies. He will be responsible for building the company's clinical development team and for the design and implementation of studies to evaluate the company's pipeline of novel antibody and protein therapeutics.
"As we move our lead XmAb anti-CD30 antibody candidate into the clinic this year for Hodgkin's disease and ...